These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26439953)

  • 21. [The serum MBP, myelin sheath immunohistochemistry and electromicroscope of expetrimental epilepsy rats].
    Chen J; Wang X; Zhou S; Wang R; Zhang Y; Li C; Zhou D
    Hua Xi Yi Ke Da Xue Xue Bao; 1996 Sep; 27(3):236-9. PubMed ID: 9389052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of serum antibodies to caudate nucleus in autistic children.
    Singh VK; Rivas WH
    Neurosci Lett; 2004 Jan; 355(1-2):53-6. PubMed ID: 14729233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral response against glial derived antigens in Parkinson's disease.
    Papuć E; Kurzepa J; Kurys-Denis E; Grabarska A; Krupski W; Rejdak K
    Neurosci Lett; 2014 Apr; 566():77-81. PubMed ID: 24594199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal immune response to brain tissue antigen in the syndrome of autism.
    Weizman A; Weizman R; Szekely GA; Wijsenbeek H; Livni E
    Am J Psychiatry; 1982 Nov; 139(11):1462-5. PubMed ID: 6182806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mercury as a hapten: A review of the role of toxicant-induced brain autoantibodies in autism and possible treatment considerations.
    Kern JK; Geier DA; Mehta JA; Homme KG; Geier MR
    J Trace Elem Med Biol; 2020 Dec; 62():126504. PubMed ID: 32534375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterium paratuberculosis and autism: is this a trigger?
    Dow CT
    Med Hypotheses; 2011 Dec; 77(6):977-81. PubMed ID: 21903338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children.
    Mostafa GA; Al-Ayadhi LY
    Eur J Paediatr Neurol; 2012 Sep; 16(5):464-8. PubMed ID: 22226851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
    O'Connor KC; Lopez-Amaya C; Gagne D; Lovato L; Moore-Odom NH; Kennedy J; Krupp L; Tenembaum S; Ness J; Belman A; Boyko A; Bykova O; Mah JK; Stoian CA; Waubant E; Kremenchutzky M; Ruggieri M; Bardini MR; Rensel M; Hahn J; Weinstock-Guttman B; Yeh EA; Farrell K; Freedman MS; Iivanainen M; Bhan V; Dilenge M; Hancock MA; Gano D; Fattahie R; Kopel L; Fournier AE; Moscarello M; Banwell B; Bar-Or A
    J Neuroimmunol; 2010 Jun; 223(1-2):92-9. PubMed ID: 20381173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Caspase-3 inhibition blocks long-term potentiation in hippocampal slices].
    Kudriashov IE; Iakovlev AA; Kudriashova IV; Guliaeva NV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2003; 53(5):537-40. PubMed ID: 14658317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels of nerve growth factor in Egyptian autistic children: Relation to hyperserotonemia and autoimmunity.
    Mostafa GA; Meguid NA; Shehab AAS; Elsaeid A; Maher M
    J Neuroimmunol; 2021 Sep; 358():577638. PubMed ID: 34214954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders.
    Connolly AM; Chez MG; Pestronk A; Arnold ST; Mehta S; Deuel RK
    J Pediatr; 1999 May; 134(5):607-13. PubMed ID: 10228297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Simplified enzyme-linked immunoadsorbent assays for myelin basic protein and antibodies to myelin basic protein].
    Chen J; Wang R; Li C; Xiong C; Wang D; Lin J; Zhang Q; Xu J; Yao J; Ling L
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Jun; 26(2):125-30. PubMed ID: 7490014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA.
    Martín-Pagola A; Ortiz-Paranza L; Bilbao JR; de Nanclares GP; Estevez EP; Castaño L; Vitoria JC
    Autoimmunity; 2007 Mar; 40(2):117-21. PubMed ID: 17364503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale.
    Ponomarenko NA; Durova OM; Vorobiev II; Belogurov AA; Telegin GB; Suchkov SV; Misikov VK; Morse HC; Gabibov AG
    Immunol Lett; 2006 Feb; 103(1):45-50. PubMed ID: 16297986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal anti-myelin basic protein antibody production in Chinese patients with multiple sclerosis.
    Tsai YL; Wang CR; Chiu HC; Chuang CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Nov; 23(4):284-90. PubMed ID: 1713143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgA autoantibodies against native myelin basic protein in a patient with MS.
    Schumacher H; Wenke NK; Kreye J; Höltje M; Marcus K; May C; Prüss H
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e569. PubMed ID: 31355305
    [No Abstract]   [Full Text] [Related]  

  • 38. HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing.
    Vergelli M; Pinet V; Vogt AB; Kalbus M; Malnati M; Riccio P; Long EO; Martin R
    Eur J Immunol; 1997 Apr; 27(4):941-51. PubMed ID: 9130648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related effects of the neuromodulator D-serine on neurotransmission and synaptic potentiation in the CA1 hippocampal area of the rat.
    Junjaud G; Rouaud E; Turpin F; Mothet JP; Billard JM
    J Neurochem; 2006 Aug; 98(4):1159-66. PubMed ID: 16790028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment.
    Warren KG; Catz I; Ferenczi LZ; Krantz MJ
    Eur J Neurol; 2006 Aug; 13(8):887-95. PubMed ID: 16879301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.